Article
Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2 in China: A case-control study
2022-12-30
Abstract excerpt
ABSTRACT <h4>Background: </h4> Real-world evidence on the effectiveness of COVID-19 vaccines marketed in China against the Omicron BA.2 variant remains scarce. <h4>Methods: </h4>: A case-control study was conducted to estimate the vaccine effectiveness (VE) of COVID-19 vaccines marketed in China, including inactivated vaccines, an Ad5-nCoV vaccine, and a recombinant protein vaccine. The study included 414 partici...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 67f8a9f7-8295-5664-82ba-da6ed6f94ae9
- DOI
- 10.22541/au.167243526.62837467/v1
